Scott Bessent, US Treasury Secretary, gave a statement noting that the market resilience has shown that the tariffs haven’t ...

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

Belgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced the submission of an extension of ...

Johnson & Johnson has announced the submission of an extension of indication application to the European Medicines Agency (EMA) seeking approval of Akeega (niraparib/abiraterone acetate) with ...

Over the past four and a half years immunity to Covid-19 has increased and the disease is mild for most people. However with it still occurring regularly in Wales older people are the most vulnerable ...

In patients on a daily prednisolone dose of less than 0.4 mg/kg/day or 20 mg, a 1–3-mg/day decrease weekly is selected. The final target dosage of systemic prednisolone is ≤0.2 mg/kg/day or 10 ...

Music and Chinese period dramas bring comfort to 13-year-old Er Yue Rou, who lives with the autoimmune disease. With help ...

Investigators created a prognostic digital pathology-based AI score to identify a subset of patients with clinically high-risk prostate cancer more likely to benefit from the addition of abiraterone ...

Prednisolone acetate ophthalmic suspension 1% is a sterile, topical anti-inflammatory agent for ophthalmic use and is ...

Objective: To examine whether acute glucocorticoid (GC) intake alters performance and selected hormonal and metabolic variables during submaximal exercise. Methods: In total, 14 recreational male ...

Introduction The clinical entity of vulvovaginal lichen planus has been recognized only in the last 30 years. [1] Management is difficult owing to the variability and inconsistency of symptoms and ...

Amneal plans to launch the product in the third quarter of 2025. According to IQVIA, U.S. annual sales for prednisolone acetate ophthalmic suspension for the 12 months ended April 2025 were about ...